Infinity Consultation Group - Medicare Mental Health Clinic in Zeeland, MI

Infinity Consultation Group is a medicare enrolled mental health clinic (Psychologist) in Zeeland, Michigan. The current practice location for Infinity Consultation Group is 156 W Washington Ave, Zeeland, Michigan. For appointments, you can reach them via phone at (833) 342-4552. The mailing address for Infinity Consultation Group is Po Box 94, Nazareth, Michigan and phone number is (833) 345-4552.

Infinity Consultation Group is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1487246245. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (833) 342-4552.

Contact Information

Infinity Consultation Group
156 W Washington Ave
Zeeland
MI 49464-1102
(833) 342-4552
Not Available

Mental Health Clinic Profile

Full NameInfinity Consultation Group
SpecialityPsychologist
Location156 W Washington Ave, Zeeland, Michigan
Authorized Official Name and PositionBernice S Pattterson (OWNER)
Authorized Official Contact8333454552
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Infinity Consultation Group
Po Box 94
Nazareth
MI 49074-0094

Ph: (833) 345-4552
Infinity Consultation Group
156 W Washington Ave
Zeeland
MI 49464-1102

Ph: (833) 342-4552

NPI Details:

NPI Number1487246245
Provider Enumeration Date02/03/2021
Last Update Date11/17/2023
Certification Date11/17/2023

Medicare PECOS Information:

Medicare PECOS PAC ID1850700253
Medicare Enrollment IDO20210623000812

News Archive

BBSRC allocates £250M for strategic investment programmes

Minister for Universities and Science, David Willetts, will today announce substantial funding that will ensure the UK's bioscience research base remains globally competitive and at the forefront of meeting the grand challenges faced by society in the coming decades. The announcement will be made by the Minister during a visit to the Babraham Research Campus, near Cambridge, and highlighted again during a major speech at the University of East Anglia in Norwich.

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

Cannabis use and risk of psychotic or affective mental health outcomes

Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.

Study explores link between long-term weight loss and health outcomes of older adults

Studies describing the effects of weight loss on health rarely consider age. However, weight loss during middle age likely has different effects on your health than does weight loss when you're 65-years-old or older-especially when you're older than 85.

Agreement provides International Oncology Network with preferential access to Altos Solutions' OncoEMR system

International Oncology Network (ION), a business unit of AmerisourceBergen's Specialty Group, has entered into an agreement with Altos Solutions that gives ION's membership of community-based oncology practices preferred access to OncoEMR, Altos Solutions' electronic medical records (EMR) system.

Read more Medical News

› Verified 7 days ago

Medical Identifiers

Medical identifiers for Infinity Consultation Group such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487246245NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103T00000XPsychologist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Infinity Consultation Group acts as a billing entity for following providers:
Provider NameBrooke L Clifton
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1588849640
PECOS PAC ID: 9739262015
Enrollment ID: I20080208000509

News Archive

BBSRC allocates £250M for strategic investment programmes

Minister for Universities and Science, David Willetts, will today announce substantial funding that will ensure the UK's bioscience research base remains globally competitive and at the forefront of meeting the grand challenges faced by society in the coming decades. The announcement will be made by the Minister during a visit to the Babraham Research Campus, near Cambridge, and highlighted again during a major speech at the University of East Anglia in Norwich.

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

Cannabis use and risk of psychotic or affective mental health outcomes

Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.

Study explores link between long-term weight loss and health outcomes of older adults

Studies describing the effects of weight loss on health rarely consider age. However, weight loss during middle age likely has different effects on your health than does weight loss when you're 65-years-old or older-especially when you're older than 85.

Agreement provides International Oncology Network with preferential access to Altos Solutions' OncoEMR system

International Oncology Network (ION), a business unit of AmerisourceBergen's Specialty Group, has entered into an agreement with Altos Solutions that gives ION's membership of community-based oncology practices preferred access to OncoEMR, Altos Solutions' electronic medical records (EMR) system.

Read more Medical News

› Verified 7 days ago

Provider NameSarah J Muench
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1366679359
PECOS PAC ID: 0143475293
Enrollment ID: I20130221000413

News Archive

BBSRC allocates £250M for strategic investment programmes

Minister for Universities and Science, David Willetts, will today announce substantial funding that will ensure the UK's bioscience research base remains globally competitive and at the forefront of meeting the grand challenges faced by society in the coming decades. The announcement will be made by the Minister during a visit to the Babraham Research Campus, near Cambridge, and highlighted again during a major speech at the University of East Anglia in Norwich.

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

Cannabis use and risk of psychotic or affective mental health outcomes

Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.

Study explores link between long-term weight loss and health outcomes of older adults

Studies describing the effects of weight loss on health rarely consider age. However, weight loss during middle age likely has different effects on your health than does weight loss when you're 65-years-old or older-especially when you're older than 85.

Agreement provides International Oncology Network with preferential access to Altos Solutions' OncoEMR system

International Oncology Network (ION), a business unit of AmerisourceBergen's Specialty Group, has entered into an agreement with Altos Solutions that gives ION's membership of community-based oncology practices preferred access to OncoEMR, Altos Solutions' electronic medical records (EMR) system.

Read more Medical News

› Verified 7 days ago

Provider NameBernice Patterson
Provider TypePractitioner - Psychologist Billing Independently
Provider IdentifiersNPI Number: 1225383375
PECOS PAC ID: 2769891167
Enrollment ID: I20210623001029

News Archive

BBSRC allocates £250M for strategic investment programmes

Minister for Universities and Science, David Willetts, will today announce substantial funding that will ensure the UK's bioscience research base remains globally competitive and at the forefront of meeting the grand challenges faced by society in the coming decades. The announcement will be made by the Minister during a visit to the Babraham Research Campus, near Cambridge, and highlighted again during a major speech at the University of East Anglia in Norwich.

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

Cannabis use and risk of psychotic or affective mental health outcomes

Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.

Study explores link between long-term weight loss and health outcomes of older adults

Studies describing the effects of weight loss on health rarely consider age. However, weight loss during middle age likely has different effects on your health than does weight loss when you're 65-years-old or older-especially when you're older than 85.

Agreement provides International Oncology Network with preferential access to Altos Solutions' OncoEMR system

International Oncology Network (ION), a business unit of AmerisourceBergen's Specialty Group, has entered into an agreement with Altos Solutions that gives ION's membership of community-based oncology practices preferred access to OncoEMR, Altos Solutions' electronic medical records (EMR) system.

Read more Medical News

› Verified 7 days ago

Provider NameMary Jo Baweja
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1376285494
PECOS PAC ID: 2769859974
Enrollment ID: I20221101001183

News Archive

BBSRC allocates £250M for strategic investment programmes

Minister for Universities and Science, David Willetts, will today announce substantial funding that will ensure the UK's bioscience research base remains globally competitive and at the forefront of meeting the grand challenges faced by society in the coming decades. The announcement will be made by the Minister during a visit to the Babraham Research Campus, near Cambridge, and highlighted again during a major speech at the University of East Anglia in Norwich.

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

Cannabis use and risk of psychotic or affective mental health outcomes

Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.

Study explores link between long-term weight loss and health outcomes of older adults

Studies describing the effects of weight loss on health rarely consider age. However, weight loss during middle age likely has different effects on your health than does weight loss when you're 65-years-old or older-especially when you're older than 85.

Agreement provides International Oncology Network with preferential access to Altos Solutions' OncoEMR system

International Oncology Network (ION), a business unit of AmerisourceBergen's Specialty Group, has entered into an agreement with Altos Solutions that gives ION's membership of community-based oncology practices preferred access to OncoEMR, Altos Solutions' electronic medical records (EMR) system.

Read more Medical News

› Verified 7 days ago

Provider NameDanielle Acker
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1558719914
PECOS PAC ID: 2668816935
Enrollment ID: I20240215000871

News Archive

BBSRC allocates £250M for strategic investment programmes

Minister for Universities and Science, David Willetts, will today announce substantial funding that will ensure the UK's bioscience research base remains globally competitive and at the forefront of meeting the grand challenges faced by society in the coming decades. The announcement will be made by the Minister during a visit to the Babraham Research Campus, near Cambridge, and highlighted again during a major speech at the University of East Anglia in Norwich.

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

Cannabis use and risk of psychotic or affective mental health outcomes

Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.

Study explores link between long-term weight loss and health outcomes of older adults

Studies describing the effects of weight loss on health rarely consider age. However, weight loss during middle age likely has different effects on your health than does weight loss when you're 65-years-old or older-especially when you're older than 85.

Agreement provides International Oncology Network with preferential access to Altos Solutions' OncoEMR system

International Oncology Network (ION), a business unit of AmerisourceBergen's Specialty Group, has entered into an agreement with Altos Solutions that gives ION's membership of community-based oncology practices preferred access to OncoEMR, Altos Solutions' electronic medical records (EMR) system.

Read more Medical News

› Verified 7 days ago

News Archive

BBSRC allocates £250M for strategic investment programmes

Minister for Universities and Science, David Willetts, will today announce substantial funding that will ensure the UK's bioscience research base remains globally competitive and at the forefront of meeting the grand challenges faced by society in the coming decades. The announcement will be made by the Minister during a visit to the Babraham Research Campus, near Cambridge, and highlighted again during a major speech at the University of East Anglia in Norwich.

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

Cannabis use and risk of psychotic or affective mental health outcomes

Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.

Study explores link between long-term weight loss and health outcomes of older adults

Studies describing the effects of weight loss on health rarely consider age. However, weight loss during middle age likely has different effects on your health than does weight loss when you're 65-years-old or older-especially when you're older than 85.

Agreement provides International Oncology Network with preferential access to Altos Solutions' OncoEMR system

International Oncology Network (ION), a business unit of AmerisourceBergen's Specialty Group, has entered into an agreement with Altos Solutions that gives ION's membership of community-based oncology practices preferred access to OncoEMR, Altos Solutions' electronic medical records (EMR) system.

Read more News

› Verified 7 days ago

Psychologist in Zeeland, MI

Winning At Home, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 300 S State St, Zeeland, MI 49464
Phone: 616-772-1733    Fax: 616-879-0072
Muddy Miracles
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 300 S State St Ste 13, Zeeland, MI 49464
Phone: 616-772-1733    
Headwaters Counseling, Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 201 W Washington Ave Ste 280, Zeeland, MI 49464
Phone: 616-259-5452    Fax: 616-236-0875
Pine Rest Christian Mental Health Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8333 Felch Street, Medical Office Building, Zeeland, MI 49464
Phone: 616-741-3790    
Hope Discovery Aba Services, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 201 Royal Park Dr, Zeeland, MI 49464
Phone: 616-970-4172    
Natasha Rietveld Postma, Lmsw, Plc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2636 E Chester Dr, Zeeland, MI 49464
Phone: 616-546-0433    
Witteveen Counseling, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 300 S State St, Ste 13, Zeeland, MI 49464
Phone: 616-772-1733    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.